ROSE DAVID: Open Payments
NPI 1245876960 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,594 in 49 payments from 18 companies in 2025. Trend: 2023 $603 · 2024 $1,172 · 2025 $1,594
Food & beverage: $1,594
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $254 |
| Travere Therapeutics, Inc. | 7 | $232 |
| Amgen Inc. | 5 | $195 |
| SCPHARMACEUTICALS INC. | 4 | $172 |
| Calliditas Therapeutics US Inc. | 4 | $147 |
| Lilly USA, LLC | 3 | $127 |
| Novo Nordisk Inc | 4 | $101 |
| AKEBIA THERAPEUTICS INC | 2 | $77 |
| Apellis Pharmaceuticals, Inc. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
Products named: Vanrafia, TAVNEOS, FUROSCIX, TARPEYO, Vafseo, Fabhalta, Empaveli, Kerendia.
Industry payments across MI — which companies pay providers there.
